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Abstract
Background: Although patients with chronic hepatitis C (CHC) have been found to have reduced
quality of life, little is known about how other characteristics affect their quality of life. The purpose
of this study was to investigate the effect of other characteristics, including history of cancer, on
quality of life in patients with CHC.
Methods: One hundred forty patients from clinics at three hospitals in New York City completed
a detailed epidemiologic interview about demographic and lifestyle characteristics and the SF-36
measuring health-related quality of life. We compared results from our patients to normative data
using t-tests of differences between means. We used multivariate analyses to determine other
personal and health-related factors associated with quality of life outcomes.
Results: Compared to normative data, these patients had reduced quality of life, particularly on
physical functioning. The summary Physical Component Score (PCS) was 45.4 ± 10.6 and the
Mental Component Score (MCS) was 48.2 ± 11.1, vs norms of 50 ± 10.0; p-values were <0.0001
and <0.05, respectively. In multivariate analyses, the PCS was significantly lower among those with
cancer history, ≥ 2 other chronic conditions, less education, low physical activity, and higher alanine
aminotransferase (ALT) levels. Cancer was more important for men, while other chronic
conditions were more important for women. On the MCS, history of depression, low physical
activity, alcohol use, and female gender were independently associated with poorer scores.
Conclusion: Several health and lifestyle factors independently influence quality of life in CHC
patients. Different factors are important for men and women.
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Background
Several studies investigating health-related quality of life
have found reduced quality of life in patients with chronic
hepatitis C (CHC), particularly on measures relating to
physical functioning. Because of the types of exposures
leading to CHC, these patients are likely to have other
demographic, lifestyle, and health-related factors that
affect their quality of life; such factors have not been well-
evaluated in previous studies. Most studies of quality of
life in this patient population have been conducted
among patients who were taking part in clinical trials [1-
6]. There has been less emphasis on the quality of life of
patients in a clinic setting, who are more typical of
patients with CHC. Our study of hepatitis C in three hos-
pitals in New York City includes patients from a cancer
center, many of whom have had cancer, and patients from
a community hospital in Harlem.
We collected information on quality of life and detailed
information on other lifestyle and health factors that are
likely to be related to quality of life. We hypothesized that
health-related quality of life among these patients would
be reduced compared to the general population and that
other health and lifestyle factors would have an impact on
poorer quality of life.
Methods
Study population
Patients who tested positive for hepatitis C virus (HCV) by
PCR (polymerase chain reaction) were approached at out-
patient clinics at Memorial Sloan-Kettering Cancer Center
(MSKCC), North General Hospital (NGH), and Mt. Sinai
Hospital. We began the study at these institutions in June
2000, October 2001, and May 2003, respectively, follow-
ing approval by the Institutional Review Boards at each
site. Those eligible for the study were aged 18 years or
older, English-speaking, and approved for the study by
their physician. The overall response rate to the study was
66% of those approached. There were 188 patients who
completed both the main questionnaire and the SF-36.
Twenty-three were excluded from this analysis because
they had sustained response to treatment, defined as hav-
ing negative PCR for at least two measurements at least 6
months apart. Also excluded were 23 patients who com-
pleted the SF-36 while on treatment for HCV and two who
completed it while being treated for cancer; they were
excluded because treatment is likely to lead to short-term
reduction in quality of life. This analysis is based on 140
patients.
Collection of epidemiologic, quality of life, and clinical 
data
After obtaining informed consent, the medical interviewer
administered a questionnaire to determine demographic
characteristics, medical history, the probable route of
infection, and other lifestyle factors. Information on
health-related quality of life was collected by use of the SF-
36. This is a validated and frequently-used instrument that
includes 36 questions on quality of life, grouped into
eight domains: physical functioning, general health per-
ception, pain, social functioning, role limitations-emo-
tional, role limitations-physical, vitality, and mental
health. These eight domains can be summarized in two
overall measures, the Physical Component Scale (PCS)
and the Mental Component Scale (MCS). Using standard-
ized methods [7,8], we recalibrated raw scores as required,
imputed missing values for individual questionnaire
items where possible, and transformed scores for each
domain to a scale of 0 to 100.
We calculated summary measures for the PCS and MCS
and transformed them using norm-based scoring, which
results in a mean of 50 and SD of 10 in the general U.S.
population [8]. Because of missing data on some of the
domains, the number of patients with PCS and MCS
scores was 136. Higher scores on these measures indicate
better health. Information on clinical factors, such as
treatment, stage, and ALT level was abstracted from medi-
cal records. Data on ALT were missing for two patients.
Statistical methods
Data were analyzed using SAS. Normative data on the PCS
and MCS summary scales have been published for the
general U.S. population, based on a survey conducted in
1990 [8]. We compared mean scores of our patients to
these norms, in total and for men and women separately.
We used t-tests for independent samples to compare
means on the eight domains and on the PCS and MCS
summary scales in subgroups of our patients defined by
demographic factors (e.g., gender) and health factors (e.g.,
presence of chronic conditions). For those variables for
which statistically significant differences were found in
the PCS and MCS between subgroups of patients, we used
multivariate general linear models to determine which of
these variables were independently related to the PCS and
MCS scores. Because of our interest in the effects of cancer
history, we also included this factor in these models.
Results
Characteristics of patients
About half of the patients in this study were men (53%)
and the mean age was 53.4 years (SD 11.4, range 23 to
87). Men were younger than women (50.8 vs 56.3, p <
0.01). Eighty-six percent were from MSKCC, with most of
the rest from NGH. About half were Caucasian and about
one-third were African-American. While more than half
had at least some college education, 20% had not gradu-
ated from high school. Forty-seven percent were currently
employed. Two-thirds were physically active when inter-
viewed, participating in physical activities such asHealth and Quality of Life Outcomes 2005, 3:39 http://www.hqlo.com/content/3/1/39
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walking, sports, aerobics, running or other activity more
than once a week. Forty-eight percent had a previous diag-
nosis of cancer. These are mainly long-term cancer survi-
vors, with a mean of 9.4 years since diagnosis (median 6.6
years, range 4 months to 38 years).
Diagnosis of cancer and years since diagnosis were the
same in men and women. Among these patients, most
had breast cancer (n = 17), followed by lymphoma (n =
14), colon cancer (n = 7), testicular cancer (n = 6), pros-
tate cancer (n = 5) and leukemia (n = 5). Among all
patients, other conditions were common: 72% had at
least one chronic medical condition (heart disease, diabe-
tes, hypertension, lung disease, thyroid disease, arthritis,
rheumatoid arthritis, asthma, stroke or transitional
ischemic attack, Crohn's disease, colitis, ulcers, or psoria-
sis); the highest prevalences were for hypertension (37%)
and arthritis (22%). Forty-three percent had two or more
of these conditions. Women were more likely than men to
have heart disease and thyroid disease and to have two or
more conditions.
One-quarter of the patients had been diagnosed with
depression at some time and 15% were currently being
treated for depression; more women than men ever had
depression. Using responses to questions on the amount
of beer, wine, and hard liquor drunk and the frequency of
drinking each type of alcohol, we determined that 36% of
respondents had a history of high alcohol consumption,
defined as drinking an average of >2 drinks per day of
beer, wine, or hard liquor for men and >1 drink per day
for women [9]. Among those with heavy use of alcohol,
22% continued to drink in the last year, while among
those who had stopped drinking, the mean number of
years since drinking was 8.8 ± 7.4 (range, 1–30 years). The
most common route of infection was IV drug use, for
40%, with 30% infected through transfusions and 30%
infected through other or unknown routes. The mean
number of years since using IV drugs was 19, and none
claimed to have used IV drugs in the past 1.5 years. Sixteen
patients (11%) had a positive test for human immunode-
ficiency virus (HIV) by self-report. Four percent were
treated for hepatitis C before completing the SF-36; the
mean number of months between completing treatment
and filling out the questionnaire was 11.7 ± 10.1 (range
1–27 months). An additional 18% were treated after fill-
ing out the SF-36. ALT levels close to the time of complet-
ing the SF-36 questionnaire (mean 19.7 days, range 0–
163) were available for 137 patients: the median was 56
and 20% had ALT levels of 100 or above. Among the 81
patients who had liver biopsy, 42% had stage III-IV dis-
ease, including 12% with stage IV.
Comparison with population norms
Table 1 shows the results for the summary measures, the
PCS and MCS. Compared to the norm of 50 among the
general U.S. population, patients with CHC scored lower
on these measures, particularly the PCS. Compared to
men in the general population, men with CHC scored
below the norm for men on the PCS, but were equal to the
norm on the MCS. In contrast, women with CHC scored
Table 1: Mean scores (SD) on PCS and MCS for patients with CHC and general U.S. population
Total Men Women
CHC patients 
(n = 136)
General 
population
(n = 2474)
CHC patients 
(n = 72)
General 
population
(n = 1055)
CHC patients 
(n = 64)
General 
population
(n = 1412)
PCS 45.4a (10.6) 50.0 (10) 47.3b (10.1) 51.0 (9.4) 43.3a (10.9) 49.1 (10.4)
MCS 48.2c (11.1) 50.0 (10) 50.7 (9.4) 50.7 (9.6) 45.3b (12.2) 49.3 (10.3)
General population data from Ware & Kosinski, 2001
a p < 0.0001
b p < 0.01
c p < 0.05
Table 2: Mean scores (SD) on eight domains
Transformed to 
norms 
(n = 140)
Not transformed 
(n = 140)
Physical functioning 45.6 (11.3) 72.7 (27.8)
Role limitation – physical 46.3 (9.3) 66.3 (33.7)
Bodily pain 47.0 (12.4) 64.1 (29.1)
General health 44.0 (11.4) 57.1 (24.9)
Vitality 48.7 (11.4) 54.7 (24.5)
Social functioning 45.5 (12.8) 73.8 (29.7)
Role – emotional 48.0 (8.8) 78.5 (27.1)
Mental health 46.4 (12.2) 69.2 (21.5)Health and Quality of Life Outcomes 2005, 3:39 http://www.hqlo.com/content/3/1/39
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below the norms for women on both these summary
scales.
Domains of quality of life
Table 2 shows scores for the individual domains. The first
column shows transformed results, scaled to the norm of
50; transformation accounts for differences in the struc-
ture of the scales and allows for comparison between
scales. The second column shows scores before transfor-
mation, to facilitate comparison to other studies. On the
transformed scores, the CHC patients in our study had the
highest scores for vitality and role-emotional (i.e., the
extent to which emotional problems interfere with daily
activities), and the lowest for general health.
Factors associated with PCS and MCS
In univariate analysis, shown in Table 3, female gender,
lower physical activity, history of heavy alcohol use and
history of depression led to lower scores on both the PCS
and MCS. Other variables that were associated with signif-
icantly lower PCS scores on univariate analysis were hav-
ing less than a high school education, not working
currently, and having two or more chronic conditions.
Those with a high ALT level (i.e., ALT >100) close to the
time of completing the SF-36 had lower scores on the PCS
that were marginally significant. We included these varia-
bles in multivariate analyses of factors affecting the PCS
score. In addition, because of our interest in quality of life
among cancer patients with CHC, we included history of
cancer in the models.
Results of multivariate models for the PCS incorporating
these variables are shown in Table 4. History of cancer and
having two or more other conditions were strongly asso-
ciated with the PCS, and high ALT level, having fewer
Table 3: Patient characteristics and mean PCS and MCS scores (SD) according to patient characteristics
#% P C S M C S
Total 136 100 45.4 (10.6) 48.2 (11.1)
Gender Male
Female
72
64
53 47 47.3 (10.1) 43.3 (10.9)a 50.7 (9.4) 45.3 (12.2)b
Education <12 years
≥12 years
28 108 21 79 40.8 (10.9) 46.6 (10.3)b 45.9 (12.0) 48.7 (10.8)
Currently employed No
Yes
74
62
54 46 42.4 (10.7) 49.0 (9.4)c 47.5 (11.7) 48.9 (10.3)
Physical activityd ≤once/week >once/week 44
92
32 68 41.8 (11.4) 47.1 (9.9)b 44.6 (12.3) 49.9 (10.1)b
History of cancer Yes 65 48 43.8 (10.1) 47.7 (10.4)
No 71 52 46.9 (11.0) 48.6 (11.7)
Number of chronic conditionse <2
≥2
76
60
56 44 48.8 (9.9) 41.1 (10.0)c 49.7 (8.8) 46.2 (13.3)
History of depression Yes 36 26 40.3 (10.3) 41.9 (10.6)
No 100 74 47.2 (10.2)c 50.4 (10.4)c
ALT ≥100 26 20 42.0 (10.1) 49.9 (9.4)
<100 107 80 46.4 (10.6) 47.8 (11.3)
History of heavy alcohol usef Yes 49 36 42.6 (11.1) 45.1 (11.7)
No 87 64 47.0 (10.1)a 49.9 (10.4)a
a p < 0.05 b p < 0.01 c p < .001. Numbers shown are for total sample, although actual number varies slightly for individual scales.
d patients with high levels of physical activity participated in activities such as walking, jogging, active sports, aerobic exercises, and heavy physical 
activity at work more than once a week
e includes heart disease, diabetes, hypertension, lung disease, thyroid disease, arthritis, asthma, stroke or transitional ischemic attack, Crohn's 
disease, colitis, ulcers, and psoriasis
f >2 drinks of beer, wine, or liquor per day, on average, for men, and >1 drink per day for women.
Table 4: F values for factors associated with PCS in multivariate 
analysis in total and by gender
Total 
(n = 133)
Men 
(n = 71)
Women 
(n = 62)
Female gender 2.27 NA NA
<12 years education 5.68a 3.36 2.67
Not currently employed 2.90 0.40 1.01
Low physical activity 5.50a 3.12 0.93
History of cancer 10.13b 9.98b 1.15
≥2 chronic conditions 15.00c 3.14 12.99c
History of depression 2.72 0.39 3.97
ALT ≥100 8.26b 3.97 3.65
History of heavy alcohol use 1.65 0.15 2.23
r2 .39 .31 .51
NA – not applicable
a p < 0.05 b p < 0.01 cp < 0.001Health and Quality of Life Outcomes 2005, 3:39 http://www.hqlo.com/content/3/1/39
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years of education, and low physical activity also had a
significant effect on the PCS score. Although gender had
an important effect in univariate analysis, it was strongly
related to education and depression, with women having
less education and higher prevalence of depression; with
all these variables in the model, only education had an
independent effect. Current employment and alcohol use
were not significant in multivariate analysis. The variables
in the model explained 39% of the variation in the PCS.
Results of multivariate analysis differed by gender: among
men, only a history of cancer was associated with the PCS,
while among women, only chronic conditions affected
the score. The variables included in the models explained
more of the variance for women than for men.
In univariate analysis (Table 3), the factors associated
with the MCS were depression, level of physical activity,
gender, and alcohol consumption. These factors and can-
cer history were included in multivariate models. Results,
shown in Table 5, indicate that each of these factors,
except history of cancer, was independently associated
with MCS, explaining 23% of the variance. Among men,
only physical activity was significant, and among women,
depression and alcohol use were significant.
We also investigated several other factors for their associ-
ation with the PCS and MCS, in both univariate and mul-
tivariate analyses. Variables not related to these quality of
life measures included: age, race, marital status, hospital,
HIV infection, route of transmission, treatment for CHC,
stage of fibrosis, and measures of social support (attend-
ance at religious services, attendance at meetings of com-
munity groups, and number of friends).
Discussion
As we hypothesized, quality of life was reduced in this
population and was related to other physical and lifestyle
conditions in these study participants. Our extensive epi-
demiologic information allowed us to study a number of
factors that have not been addressed in other studies and
provides an understanding of how these factors affect
quality of life in patients with HCV.
Six other studies [10-15] have analyzed health-related
quality of life in patients with CHC in clinic settings.
Untransformed scores on the eight domains among our
patients were generally similar to those reported in these
studies, although on several domains our scores tended to
be somewhat higher. Hussain et al. [11] reported PCS and
MCS summary scores and results according to several
patient characteristics. Comparing our results to those,
patients in the present study had similar scores on the PCS
(45 vs 44) and significantly higher scores on the MCS (48
vs 44, p < 0.01).
Differences in patient characteristics make comparisons
somewhat uncertain; our study included higher propor-
tions of women and a lower proportion who were
employed, but a higher proportion with at least a high
school education. Consistent with our results from uni-
variate analysis, Hussain et al. [11] reported that women,
those with less education, and those with comorbid ill-
nesses had lower scores on the PCS. The two studies were
also consistent in reporting no association with age or
drug use. Consistent results were also reported by Fontana
et al. [12], who found that painful comorbid conditions,
such as arthritis or migraine headaches, and current
depression were associated with poorer quality of life in a
study in patients for whom previous interferon therapy
had failed. Two other studies considered the association
between ALT measures and quality of life [10,15], and did
not find an association, as we did. Earlier studies that
investigated patient characteristics did not use multivari-
ate methods to investigate the independence of the factors
studied. In the present study, multivariate analysis indi-
cated that gender per se was not significantly associated
with PCS scores when related variables, depression and
education, were included.
The inclusion of many patients with cancer in our setting
adds further information on the effect of chronic condi-
tions on quality of life. Overall, we found reduced quality
of life on physical measures for cancer survivors compared
to other CHC patients, especially in men, and no differ-
ence on measures reflecting mental health. The literature
on quality of life in cancer survivors indicates that quality
of life may be reduced in long-term survivors [16-20],
although a number of studies have found quality of life to
be similar to population norms or control groups [16,21-
24]. These studies were conducted in patients with differ-
ent cancers and used different instruments to measure
quality of life, making generalizations difficult.
Table 5: F values for factors associated with MCS in multivariate 
analysis in total and by gender
Total 
(n = 135)
Men 
(n = 72)
Women 
(n = 63)
Female gender 5.92a NA NA
Low physical activity 6.88b 8.43b 0.48
History of cancer 1.74 0.91 0.29
Depression 9.38b 3.14 4.77a
History of high alcohol use 5.59a 1.43 4.06a
r2 .21 .16 .21
NA – not applicable
a p < 0.05 b p < 0.01Health and Quality of Life Outcomes 2005, 3:39 http://www.hqlo.com/content/3/1/39
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To our knowledge, the influence of physical activity has
not been studied previously in patients with CHC.
Although it is not possible to separate the direction of the
association between physical activity and quality of life
(that is, people with better quality of life in general may
be more able to participate in physical activity, or those
who participate may improve their quality of life), the
finding does raise the question of whether an intervention
aimed at increasing activity might improve quality of life
in the CHC population. A small study including both die-
tary and physical activity interventions in overweight indi-
viduals with CHC (most with HCV) reported
improvement in quality of life, particularly in those who
maintained weight loss, although it was not possible to
evaluate the effects of diet and exercise separately [25]. A
large proportion of our patients reported being physically
active, probably because they are in an urban area where
walking is common.
Strengths of this study are the focus on a diverse popula-
tion of patients seen in different clinics in a major metro-
politan area, including a cancer hospital, the availability
of extensive epidemiologic data and clinical data that
allowed us to investigate the effect of other factors on
quality of life, and the use of multivariate analysis to
examine influences on quality of life. In contrast to several
other studies [1,2,4,5,12-14], we used only the SF-36 to
measure quality of life because of the extensive amount of
other information we were collecting; therefore, we did
not have the opportunity to investigate aspects of quality
of life that are more specific to hepatitis C.
Another disadvantage of this study is the relatively low
proportion of those approached who agreed to take part
in the study (66%); in addition, there were 73 patients
who completed the main questionnaire but not the SF-36.
To some extent, the level of participation reflects the char-
acteristics of this population, who often have other medi-
cal and social problems that make joining such studies
difficult. A similar response was obtained by Hussain et al.
[11], although a smaller clinical study [10] reported
nearly complete participation. It seems possible that those
who did not take part have poorer quality of life than
those who did, which would imply that quality of life in
all patients with CHC is reduced even further than that
reported here and in similar studies.
Conclusion
These results support those of other studies finding that
patients with CHC have considerable impairment of qual-
ity of life. Our analysis extends these findings to show that
other factors strongly influence quality of life in these
patients, and that all patients with CHC are not equally at
risk of reduced quality of life. In our population, quality
of life on the PCS scale was affected by medical factors
such as history of cancer, presence of other chronic condi-
tions, and ALT, as well as by social and lifestyle factors
such as education and physical activity. On the MCS scale,
quality of life was affected by history of cancer and depres-
sion, as well as by gender, alcohol use, and lack of physical
activity. In addition, women and men differed in how
these factors influenced the PCS and MCS scores. Under-
standing the degree of reduction of quality of life and
other factors that are associated with this reduction
should help clinicians deal more effectively with this
population.
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